Search
forLearn
5 / 801 resultslearn fleece-flower
learn sunflower
learn peach leaf
learn procapil
Research
5 / 110 resultsresearch Wool Fibres: Sectioning and Staining, Differentiation of Ortho and Paracortex
research Distinctive age distribution and hair loss pattern putatively highlighting uniqueness of Japanese cases of fibrosing alopecia in a pattern distribution
Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.
research A Survey on Marketed Products Having Significance Role in Hair Loss Treatment: Bhilai-Durg City 2011-12
Sesa oil, Keshking oil, and Parachute oils were the most available hair loss treatments in Bhilai-Durg city during 2011-12.
research ELECTRON MICROSCOPE STUDIES OF HAIR AND WOOL
Hair and wool have complex microscopic structures with microfibrils and varying cystine content.
research Nucleation and growth of macrofibrils in trichocyte (hard-α) keratins
Sheet formation is key to macrofibril structure differences in wool.
Community Join
5 / 1000+ resultscommunity Does Nuking Scalp DHT Theoretically Make Minoxidil Gains Permanent?
Minoxidil gains are not permanent without continued use, even with DHT suppression. Combining treatments like Dutasteride, Finasteride, and RU58841 may help maintain hair, but stopping Minoxidil typically results in hair loss.
community PP405 is a game changer. One for the history books. Era defining moment and Pelage know it.
PP405 is a new hair loss treatment that may outperform minoxidil and finasteride by growing thick hair in bald areas within four weeks. Its release is expected around 2028, but concerns about its long-term efficacy and cost remain.
community Pelage Recruiting Now for Phase 2
Pelage is recruiting for phase 2 trials, showing promise for treating bald regions. The discussion highlights its potential effectiveness based on its mechanism of action.
community Sprinkle that PP405 on my scalp like I sprinkle salt on my stake
PP405 shows promise for hair growth with significant results after 4 weeks, but skepticism exists due to its unavailability. Some users are hopeful for its potential, while others express concerns about side effects and market release delays.
community Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy
Pelage Pharmaceuticals announced positive Phase 2a trial results for PP405 in hair loss therapy. The conversation discusses the delay in publishing full results and the need for further trials and approvals.